Company Filing History:
Years Active: 2005
Title: André Van De Voorde: Innovator in Alzheimer's Research
Introduction
André Van De Voorde is a notable inventor based in Lokeren, Belgium. He has made significant contributions to the field of medical research, particularly in the study of Alzheimer's disease. His work focuses on developing innovative solutions to combat this debilitating condition.
Latest Patents
André holds a patent for "Monoclonal antibodies directed against the microtubule-associated protein tau." This monoclonal antibody forms an immunological complex with a phosphorylated epitope of an antigen belonging to human abnormally phosphorylated tau protein. The tau protein can be obtained from a brain homogenate, which is isolated from the cerebral cortex of a patient suffering from Alzheimer's disease. This patent represents a crucial step in understanding and potentially treating Alzheimer's.
Career Highlights
André is associated with N.V. Innogenetics S.A., a company known for its innovative approaches in biotechnology. His work at the company has been instrumental in advancing research related to neurodegenerative diseases. With a total of 1 patent, he has established himself as a key figure in the scientific community.
Collaborations
André has collaborated with esteemed colleagues such as Marc Mercken and Eva-Maria Mandelkow. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic strategies.
Conclusion
André Van De Voorde's contributions to Alzheimer's research through his innovative patent highlight the importance of scientific inquiry in addressing complex health challenges. His work continues to inspire advancements in the field of biotechnology.